RESIMMUNE
Live / Registered — Registered and renewed (as of 26 Feb 2024)
What this means for you
Registered since 02 Sept 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Sept 2024).
Record
- Serial number
- 85547028
- Registration number
- 4597602
- Mark type
- Stylized text
- Filed
- 20 Feb 2012
- Published for opposition
- 10 Jul 2012
- Registered
- 02 Sept 2014
- Next maintenance due
- 02 Sept 2024
- Attorney of record
- Walter W. Richardson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, immunotoxins
Owner
- Angimmune LLC, Holliston, MA, US
- Angimmune LLC, Bethesda, MD, US
- Angimmune LLC, Bethesda, MD, US
Prosecution history
- 26 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 26 Feb 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 26 Feb 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 26 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Sept 2023 — TEAS SECTION 8 & 9 RECEIVED
- 02 Sept 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 11 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 10 Jun 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 09 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Mar 2021 — TEAS SECTION 8 RECEIVED
- 02 Sept 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Sept 2014 — REGISTERED-PRINCIPAL REGISTER
- 29 Jul 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jul 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Jul 2014 — STATEMENT OF USE PROCESSING COMPLETE